Climb Bio (CLYM) Other Operating Expenses (2020 - 2024)

Climb Bio has reported Other Operating Expenses for 5 years, with the latest figure at $51.7 million in Q2 2024.

• For the quarter ending Q2 2024, Other Operating Expenses changed N/A year-over-year to $51.7 million; the trailing twelve-month figure through Mar 2025 stood at $51.7 million (changed N/A YoY), and the FY2024 full-year result was $51.7 million, changed N/A from the prior year.
• Other Operating Expenses for Q2 2024 stood at $51.7 million, up from $900000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $51.7 million in Q2 2024, with the low at $20000.0 in Q3 2021.
• Historically, Other Operating Expenses has averaged $7.8 million across 5 years, with a median of $200000.0 in 2021.
• Annual changes were most pronounced in 2021 — Other Operating Expenses tumbled 99.36% — and 2023, when it jumped 958.82%.
• Climb Bio's Other Operating Expenses stood at $9.4 million in 2020, then plunged by 99.36% to $60000.0 in 2021, then surged by 41.67% to $85000.0 in 2022, then jumped by 958.82% to $900000.0 in 2023, then jumped by 5639.89% to $51.7 million in 2024.
• The last three Other Operating Expenses figures came in at $51.7 million (Q2 2024), $900000.0 (Q1 2023), and $85000.0 (Q1 2022), per Business Quant data.